| Corgenix Medical Corporation (OTC BB: CONX.OB), a worldwide developer and marketer of diagnostic test kits, today filed its fiscal quarter Form 10-Q and reported financial results. The report disclosed that the company's operating results have advanced for the quarter ended September 30, 2011. Financial Highlights for the Quarter ended September 30, 2011 Total revenues for the quarter ended September 30, 2011, (first fiscal quarter) increased 10.1% to $2.18 million from $1.98 million in...continued CONX Healthcare Medical pharmaceuticals |
Monday, November 14, 2011
Corgenix Reports First Quarter Fiscal 2012 Financial Results
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment